Fecal egg count reduction percentage (FECRP). by Sohail Afzal (10850709)

“…EPG values were used to determine the fecal egg count reduction (FECR). Statistically, there was a significant decrease in EPG values from days 0–14. …”

Overview of the WeARTolerance program. by Ana Beato (20489933)

Subjects:

Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation by Xiaoyu Shen (4715430)

Subjects:

<i>e-lgp</i> curve of improved red clay. by Quan Shen (37564)

“…The indicate reveal that: (1) the addition of RoadyesTM alone results in a reduction in both the liquid limit and plasticity index, while simultaneously increasing cohesion and unconfined compressive strength; (2) Red clay treated with 0.25% RoadyesTM demonstrates the highest compression index, indicating optimal compressibility.; (3) The combination of RoadyesTM with cement and lime significantly enhances the mechanical properties of the red clay. …”

Analytical framework and statistical methods. by Na Chen (153323)

Subjects:

Theoretical frameworks of social protection. by Na Chen (153323)

Subjects:

Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes by Shakkira Erimban (6882539)

Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes by Shakkira Erimban (6882539)

Degeneration Saline group presented with significant decreased final weight in relation to other groups. by Flavia Gomes Velasque Gama (21175112)

Toroidal metamaterials. by Wen-Ying Zhou (10049543)

Subjects:

Human tissue dielectric parameters. by Wen-Ying Zhou (10049543)

Subjects:

Human head modeling. by Wen-Ying Zhou (10049543)

Subjects:

Variations in SAR for individual organizations. by Wen-Ying Zhou (10049543)

Subjects:

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Cohort characteristics. by Vincent Pey (21433304)

Subjects:

Aripiprazole significantly decreases phosphorylated Src (Y416) levels in dHL-60 cells. by Courtney A. Swain (15170264)

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”